A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update.

MLA

Hellwig, Kerstin, et al. “A Multi-Country Cohort Database Study to Assess Pregnancy and Infant Outcomes after Potential Maternal or Paternal Exposure to Cladribine Tablets in the Treatment of Multiple Sclerosis: The CLEAR Study Methods and Status Update.” Therapeutic Advances in Neurological Disorders, Jan. 2025, pp. 1–15. EBSCOhost, https://doi.org/10.1177/17562864241310996.

APA

Hellwig, K., Magyari, M., MacDonald, T. M., Cesta, C. E., Wergeland, S., Leinonen, M. K., Ornoy, A., Vukusic, S., Lauer, A., Zhou, X., Kawai, A., Weinrib, R., Arana, A., & Boumenna, T. (2025). A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update. Therapeutic Advances in Neurological Disorders, 1–15. https://doi.org/10.1177/17562864241310996

Chicago

Hellwig, Kerstin, Melinda Magyari, Thomas M. MacDonald, Carolyn E. Cesta, Stig Wergeland, Maarit K. Leinonen, Asher Ornoy, et al. 2025. “A Multi-Country Cohort Database Study to Assess Pregnancy and Infant Outcomes after Potential Maternal or Paternal Exposure to Cladribine Tablets in the Treatment of Multiple Sclerosis: The CLEAR Study Methods and Status Update.” Therapeutic Advances in Neurological Disorders, January, 1–15. doi:10.1177/17562864241310996.